Nachi Palaniappan

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

Waheeda Owadally, Chris Hurt, Hayley Timmins et al. · BMC Cancer · 2015 · 263 citations · Full text

Medicine, Oncology, Oral Surgery +17

Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial

Rathie Rajendram, Peter Taylor, Victoria Wilson et al. · The Lancet Diabetes & Endocrinology · 2018 · 105 citations · Full text

Medicine, Ophthalmology, Radiation Oncology +8

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E. Brown, Kara‐Louise Royle, Walter M. Gregory et al. · The Lancet Oncology · 2023 · 81 citations · Full text

Medicine, Oncology, Pharmacology +11

Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil

Thomas Rackley, Wanangwa C. Namelo, Nachi Palaniappan et al. · Head & Neck · 2016 · 33 citations

Medicine, Oncology, Surgery +10

Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy

Saly Al‐Taei, Russell Banner, Ned Powell et al. · Cancer Immunology Immunotherapy · 2013 · 23 citations · Full text

Life Sciences, Immunology, Oncology +14